Israeli company Intec Pharma has announced that following the successful phase II clinical trial for its accordion capsule, the capsule and procedure will receive a US patent. The accordion capsule is designed to treat advanced Parkinson’s disease.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Israel Foodtech Firms Meet UK Retailers, Investors In London
April 17, 2024
Facebook comments